Some groups have demonstrated that PD-1-blocking scFv secreting CAR-T cells significantly prolonged the survival time of tumor-bearing (166) and CAR-T cells overexpressing the PD-1 dominant negative receptor could act as a “decoy receptor” to bind and block PD-L1/2 inhibitory signals (167). The gene discussed is CD274; the disease is neoplasm.